Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Indivior Plc ADR
(OP:
INVVY
)
N/A
UNCHANGED
Last Price
Updated: 10:23 AM EDT, Jun 9, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
21.85
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Indivior Reaches $102.5M Settlement To Resolve Antitrust Litigation
June 05, 2023
Indivior PLC (OTCPK:INVVY) (OTCPK:IZQVF) (LSE: NDV), an addiction treatment company, announced that its subsidiary, Indivior Inc., has reached an agreement to resolve the claims brought by the...
Via
Benzinga
Activist Investor Recommends Yelp Explore Sale, Micron Projects China Ban To Curb Revenues, Spruce Point Capital Raises Concerns About Perion Network's Financial Practices: Today's Top News
May 23, 2023
Wall Street Journal
Via
Benzinga
Performance
More News
Read More
Nasal-Spray Millionaire: Indivior's Opvee Nasal Spray Gets FDA Green Light for Opioid Overdose Treatment
May 23, 2023
Via
Benzinga
Indivior Acquires Opiant Pharmaceuticals Strengthening Its Addiction Treatment And Science Portfolio
March 03, 2023
Via
Benzinga
Indivior Targeting Listing On NASDAQ For The Spring Of 2023
December 07, 2022
Via
Benzinga
Facebook Stalls Portal & Smartwatch Projects, Visa Breaks Debit Card Tie Up With FTX, $3B Bitcoin Withdrawn From Crypto Exchanges: Top Stories Monday, Nov. 14
November 14, 2022
Via
Benzinga
Indivior To Pay Over 100% Premium To Buy Opioid Focused Player Opiant Pharmaceuticals
November 14, 2022
Via
Benzinga
Hypocrisy All Around: Pfizer, NFL Are Hidden Sponsors Of Anti-Drug Group Fighting Against Cannabis Legalization
August 17, 2022
Via
Benzinga
Indivior Positioned To Profit If Aelis Farma's Study Of Cannabis Use Disorder Succeeds
June 01, 2022
Via
Benzinga
Indivior Study Shows Buprenorphine May Mitigate Fentanyl-Induced Respiratory Depression In Chronic Opioid Users
April 11, 2022
Via
Benzinga
Cannabis Movers & Shakers: MedMen, IM Cannabis, Avicanna, Avant Brands
January 13, 2022
Via
Benzinga
Using Opioid Addiction Drug Buprenorphine May Cause Dental Issues, FDA Flags
January 13, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.